In cancer-associated EMT, SNAI1 serves as an imperative factor in driving the transition by strongly repressing E-cadherin and tight junction components (claudins), while also upregulating mesenchymal marker proteins, including vimentin and fibronectin (84). Here, CDH1 is linked to cancer.